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Abstract 
 
Background: Gestational diabetes mellitus (GDM) is associated with maternal and fetal complications. Specific 
outcomes in previous pregnancies are considered as risk factors for GDM in the consecutive pregnancies. The 
aim of this study was to evaluate the pregravid risk factors of GDM in multigravid women. 
 
Methods: We conducted a retrospective cross sectional study on 114 multigravid women with GDM without 
previous history of diabetes and compared them with non-diabetic controls. We used modified criteria of Carpen-
ter and Coustan for screening. Risk factors were obtained from medical records of individuals.  
 
Results: We found that women of 26 years and older who had previous neonates with birth weight more than 
3800 gram and those affected with hypothyroidism or chronic hypertension were at risk for GDM. The difference 
of the number of preterm birth in GDM women and healthy controls was statistically significant (p=0.05). There 
was no significant difference between the numbers of pregnancies, parity, previous fetal and neonatal death and 
abortion number between patients and the control group.  
 
Conclusion: Our results show that maternal age over 26 years, birth weight of previous neonate more than 3800 g, 
hypothyroidism, chronic hypertension and probably history of preterm birth are significant risk factors for GDM. 
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Introduction 
 
Gestational diabetes mellitus (GDM) is defined as 
diabetes which is first discovered or has its onset dur-
ing pregnancy. The prevalence of this disease varies 
between populations from 1% to 16% because of the 
differences in the populations and the diagnostic 
methods used.
1-3 In Iran, according to separate studies 
by Hossein-nezhad and Khooshideh, GDM preva-
lence was estimated 4-8.9%.
4-6 GDM is not only as-
sociated with maternal complications but also with 
fetal problems that could impose a great burden on 
health systems. Maternal complications include preg-
nancy induced hypertension and preeclampsia, prem-
ature  
ruptures of membranes, preterm birth and the in-
creased risk of cesarean section. Affected women are 
in an increased risk for diabetes in the following 
years.
7-9 The fetuses whose mothers have experienced 
gestational diabetes mellitus are at increased risk of 
macrosomia and being large for gestational age which 
put them in the risk of birth trauma, shoulder distocia, 
neonatal hypoglycemia and neonatal death.
10  
In medical sciences, identification of risk factors is 
very important. If we can determine the risk factors, 
we can identify the population at risk and design 
some interventions to prevent the disease. Moreover, 
if the disease established, we can diagnose it in early 
stages and prevent its progression and decrease its 
complications. There are lots of studies which have 
evaluated the common risk factors of GDM. The obe-
sity before pregnancy and high weight gain during 
pregnancy, family history of diabetes mellitus, high 
maternal age, some ethnic backgrounds and previous 
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diagnosis of gestational diabetes, impaired fasting 
glucose or impaired glucose tolerance predispose 
women to GDM.
4,11-13 In this study, we evaluated the 
previous history of those multiparous women with no 
previous history of overt or gestational diabetes melli-
tus and compared them with the healthy multiparous 
control group to find potential risk factors which are 
associated with GDM. 
 
 
Materials and Methods 
 
We conducted a retrospective cross sectional study 
using the medical records of pregnant women came to 
Antenatal Clinic of Imam Khomeini Hospital, the 
largest teaching hospital of Tehran University of 
Medical Sciences in Tehran, Iran, over a period of 
two years. The patient’s files were randomly selected. 
Primigravid women and those with previous history 
of overt diabetes or GDM were excluded from the 
study. The test group was consisted of 114 multipa-
rous pregnant women with first diagnosis of GDM 
and the control group was consisted of 113 pregnant 
healthy ones. We used modified criteria of Carpenter 
and Coustan for screening. Women without previous-
ly diagnosed diabetes underwent fifty gram non-
fasting one hour glucose challenge test between 24 to 
28 weeks of gestation. Women who had a blood sugar 
more than 140 mg/dl underwent a 100-gram three 
hour glucose tolerance test after three days of a high 
carbohydrate diet. If two or more of the plasma glu-
cose measurements meet or exceed the following 
thresholds, the diagnosis of GDM was confirmed: 
fasting plasma glucose=95 mg/dl, one hour plasma 
glucose=180 mg/dl, two hour plasma glucose=155 
mg/dl and three hour plasma glucose=140 mg/dl.
3 
Diagnosis of hypothyroidism was made by evaluating 
the TSH and free T4 levels which were measured at 
the central laboratory of the hospital. Reference range 
for TSH was 0.35–4 mU/I for this laboratory. Women 
with TSH more than 4 and free T4 below the lower 
limit were considered to have hypothyroidism. Statis-
tical analysis was performed with SPSS software 
(version 15.0 for windows, Chicago, IL, USA). 
Means, standard deviations (SDs) and percentages 
were used to describe continuous and categorical da-
ta, respectively. The student’s t-test, for normally dis-
tributed data, and Mann-Whitney test, for non-
normally distributed ones, were used to analyze the 
differences of continuous variables between two 
groups while the Chi-Square test was used for   
categorical data. The 2-tailed p-value less than 0.05 
was considered to be statistically significant. The 
study was approved by the Ethics Committee of 
Imam Khomeini Hospital.  
 
 
Results 
 
This study included 114 multiparous women without 
previous history of GDM or overt diabetes mellitus 
with first diagnosis of GDM in the current pregnan-
cy and 113 control subjects without any history of 
diabetes. The mean age of the test group was 
31.39±5.56 years (mean±SD) while the mean age of 
control group was 29.2±5.39 years. We found that 
risk for GDM increased significantly with increase 
in maternal age and in women of 26 years and older 
who had a 2-fold increase in risk for GDM in com-
parison with those who were younger (OR=2.1, 
p=0.028, Table 1). 
We assessed the relationship between the birth 
weight of previous neonate and GDM. The difference 
between weight of previous neonate in the test 
(3674±814 g) and control (3080±568 g) groups was 
statistically significant (p<0.001). Women whose 
previous neonates weighted more than 3800 g were at 
higher risk of GDM (OR=9.6, p<0.001, Table 1). The 
difference between number of pregnancies as well as 
parity in GDM (3.07±1.22 and 1.5±0.96 respectively) 
and control subjects (2.88±1.38 and 1.36±1.18 re-
spectively) did not reach the significance threshold 
(p=0.10 and p=0.083 respectively, Table 1).  
The prevalence of previous fetal and neonatal 
deaths compared between GDM patients (12.3% and 
3.5% respectively) and healthy controls (8% and 
6.2% respectively) were not statistically significant 
(p=0.25 and 0.2 respectively, Table 1). We did not 
find any significant association between the number 
of previous abortions and GDM in the test 
(0.57±0.96) and control groups (0.53±0.94) in our 
study (p=0.66, Table 1). We also assessed the number 
of preterm birth in GDM women (0.25±0.53) and 
healthy controls (0.17±0.49) while the difference be-
tween the groups was of borderline statistical signifi-
cance (p=0.055, Table 1). 
Furthermore, we evaluated the association be-
tween hypothyroidism as well as chronic hyperten-
sion with GDM. Women with history of hypothyroid-
ism or chronic hypertension were more prone to get 
GDM (OR=5.3, p=0.018 and OR=4.4, p=0.002 re-
spectively, Table 1). Pregravid risk factors for GDM 
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Discussion 
 
Considering that GDM can complicate the maternal 
and fetal outcomes of pregnancy and can progress to 
overt diabetes, we tried to assess risk factors which 
can be used to predict the occurrence of this disease. 
Also a lot of studies have assessed common risk fac-
tors of GDM patients and their pregnancy outcomes, 
to our knowledge, there are few studies focusing on 
the previous obstetric and medical history of GDM 
patients. In this study, we evaluated the previous ob-
stetric and medical history of multiparous women 
without a history of overt diabetes or GDM.  
Our results showed that the risk of GDM rises as 
the maternal age increases. Women of 26 years and 
older had a 2-fold increase in risk for GDM (OR=2.1, 
p=0.028). Different studies have reported different 
age threshold (25-40 years old) for increased risk of 
GDM.
5,6,14-20 
Previous studies have reported that macrosomia, 
birth weight equal or more than 4000 or 4500 gram in 
previous pregnancies, is a risk factor for GDM.
5,6,15 
Here we assessed the relation between the birth 
weight of previous neonate with the risk of GDM and 
found that women having a previous neonate with 
birth weight greater than 3800 gram were at increased 
risk for GDM (OR=9.6, p<0.001). Our results in Ira-
nian women in the present study showed that not only 
having a history of fetal macrosomia increases the 
risk of GDM, but also those women who had a neo-
nate with birth weight equal or more than 3800 gram 
were at risk for this disease. There is evidence show-
ing that significant racial and ethnic variations exist 
among women with GDM for access to and use of 
health care, presence of risk factors, and perceptions 
of health.
21 So the aforementioned results may be due 
Table 1: Comparative analysis of gestational diabetes mellitus risk factors in women in Tehran 
 
Number
P value Odds  ratio 
GDM % Control %
Maternal age        
  <26 
  ≥26 
 
16 
98 
 
14 
86 
 
29 
84 
 
26 
74 
0.028 2.1 
Fetal death  14  12.3  9  8  0.25  1.6 
Neonatal death  4  3.5 7 6.2 0.20  0.55
Hypothyroidism 10  9.3  2  1.8  0.018  5.3 
Chronic hypertension  16  14  4  3.5  0.002  4.4 
Previous neonate birth weight 
  <3800 
  ≥3800 
 
74 
40 
 
65 
35 
 
107 
6 
 
94 
6 
 
0.001  9.6 
Abortion Number 
  0 
  1 
  2 
  ≥3  
 
71 
30 
8 
5 
 
62.3 
26.3 
7 
4.4 
 
74 
26 
9 
4 
 
65.5 
23 
8 
3.5 
 
0.66 
a 
 
 
Preterm birth number 
  0 
  1 
  2 
  ≥3 
 
90 
19 
5 
0 
 
79 
17 
4 
0 
 
99 
11 
1 
2 
 
87.7 
9.7 
0.9 
1.8 
 
0.055 
a   
Number of previous pregnan-
cies 
  1-2 
  3-4 
  ≥5 
 
50 
48 
16 
 
43.8 
42.2 
14 
 
62 
39 
12 
 
54.8 
34.6 
10.6 
 
0.10
 a 
 
 
Parity 
  0 
  1 
  2 
  ≥3 
 
11 
57 
28 
18 
 
9.6 
50 
24.6 
15.8 
 
12 
70 
19 
12 
 
10.6 
62 
16.8 
10.6 
 
0.083
 a 
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to genetic and racial differences between our study 
population and those conducted in other geographic 
areas. Comparison with other studies in different coun-
tries is needed to evaluate this new threshold setting. 
In our study, the number of pregnancies as well as 
parity did not have any significant association with 
GDM, which is consistent with other studies.
5,22 Ro-
man  et al. assessed the obstetric and neonatal out-
comes in grand multiparity. Although they found that 
grand multipara had a higher rate of insulin-
dependent gestational diabetes, after doing condition-
al logistic regression, it was not an independent pre-
dictor of insulin-dependent gestational diabetes melli-
tus.
23 But in another study, it has been shown that 
grand multiparity was associated with an increased 
risk of diabetes.
24 
Some studies have shown that the fetuses whose 
mothers have experienced gestational diabetes melli-
tus are at increased risk for macrosomia and being 
large for gestational age which put them in the risk of 
birth trauma, shoulder dystocia, neonatal hypoglyce-
mia and neonatal death.
25-30 We wondered if women 
with previous history of fetal or neonatal death are at 
increased risk of GDM. Although some results 
showed that history of prior neonatal death is a risk 
factor for GDM,
31 we did not find any association be-
tween fetal or neonatal death and GDM, as the differ-
ence between the mean of previous fetal or neonatal 
deaths in test and control groups did not reach the sig-
nificant threshold (p=0.25 and p=0.20 respectively).  
A study by Khooshideh et al. has reported that re-
current miscarriage is a risk factor for GDM.
5 In 
1991, Hughes and colleagues conducted a study on 88 
women with 3 or more miscarriages and stated that 
GDM and chronic hypertension is more frequent 
comparing with the control group.
32  In our study 
however, we could not find any significant relation-
ship between abortion number and GDM (p=0.66). 
An explanation for this result could be that those 
studies were limited to just recurrent or more than 
three miscarriages but we considered all kinds of 
abortions in our study.   
Several researchers reported that a woman’s own 
birth weight is inversely associated with her risk of 
gestational diabetes.
33-35 However, others proposed 
the need for further work to confirm these results.
36  
The fetuses of women affected with GDM are at in-
creased risk of preterm birth.
31,37,38 In this study how-
ever, we assessed whether women having previous 
history of preterm birth pregnancy are at increased 
risk for GDM. Although in our study the association 
of preterm birth and GDM was of borderline signifi-
cance (p=0.055), these women may be at risk for 
GDM in later life.  
Women with type 1 diabetes are at increased risk 
for thyroid diseases,
39 but it is not clear whether ges-
tational diabetes patients are also susceptible. Amati 
et al. studied the effect of thyroid hormone status on 
insulin sensitivity and physical fitness after weight 
loss and exercise training and reported that these fac-
tors were improved in euthyroid but not in subclinical 
hypothyroid subjects.
40 In addition, it has been shown 
that subclinical hypothyroidism is associated with 
insulin resistance in patients with rheumatoid arthri-
tis.
41 A study conducted by Velija-Asimi and associ-
ates on patients with subclinical hypothyroidism 
showed that treatment of this disease could decrease 
the levels of fasting insulin and fasting and postpran-
dial glucose.
42 Also, the role of insulin resistance in 
gestational diabetes is reviewed by Mastrogiannis et 
al.
43 While insulin secretion is increased in normal 
pregnant women during pregnancy, gestational diabe-
tes patients do not get this response.
44 Moreover, in-
sulin sensitivity is decreased in these patients com-
pared to healthy subjects.
45 All these evidences show 
that there may be a link between hypothyroidism and 
gestational diabetes. 
In 2009, Torus et al. assesses the serum antioxi-
dant levels in patients with subclinical and overt hy-
pothyroidism and found that malondialdehyde, a lipid 
peroxidation marker, is increased in these patients 
compared with healthy subjects.
39 Similar results 
were reported elsewhere.
46 Chen and Scholl reviewed 
the role of oxidative stress in pregnancy and gesta-
tional diabetes mellitus.
47 Evidences showed that as 
oxidative stress increases and antioxidation defenses 
decrease, the secretion and action of insulin impair.
48 
So it seems that the increase in oxidative stress or 
decrease in anti-oxidative system in hypothyroidism 
may interfere with insulin function. 
There are evidences that physical activity could 
decrease the risk of gestational diabetes.
49 Besides, it 
has been shown that patients suffering from hypothy-
roidism are more prone to depression,
50 due to chang-
es in catecholamine system of hypothalamus–
pituitary–thyroid axis and brain serotonergic path-
ways,
51 which could limit their physical activity and 
increase the risk of gestational diabetes. 
In a recent study by Liang et al., female mice were 
fed with high saturated fat diet one month before con-
ception and during gestation to develop a mouse 
model of gestational diabetes. The test group devel-Pregravid risk factors for GDM 
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oped more insulin resistance, lipid peroxidation and 
oxidation damage, features of gestational diabetes 
model than controls.
52 Comparing with non diabetics, 
women with gestational diabetes had higher serum 
level of triglyceride, as was reported by Enquobahrie 
and colleagues that each 20 mg/dl increase in TG was 
associated with a 10% increase in GDM risk.
53 An-
other study showed that LDL and triglyceride levels 
increased in gestational diabetes women.
54 Also, the 
levels of low density lipoproteins (LDL) in patients 
with gestational diabetes were evaluated by Rizzo et 
al. In comparison with the control group, women with 
gestational diabetes had higher LDL levels.
55 Some 
studies have demonstrated that total cholesterol, LDL 
and triglycerides are increased in patients with hypo-
thyroidism and treating these patients can decrease 
their levels.
56,57 The reason is that in hypothyroidism, 
the LDL receptors decrease and LDL accumulates in 
the serum.
58 Besides, thyroid hormones enhance the 
activity of lipoprotein lipase, which lowers the levels 
of triglycerides.
59 So in hypothyroidism, the triglycer-
ides increase in serum and consequently, it can be a 
risk factor for developing gestational diabetes.   
It has been shown that hypothyroidism is a risk fac-
tor for obesity.
60,61 In addition, lots of researchers report-
ed that the risk of gestational diabetes increases as the 
BMI rise.
4,62 As a consequence, hypothyroid patients are 
at increased risk of getting gestational diabetes. 
Our results showed that chronic hypertension is 
more prevalent in GDM women (p=0.002), which 
raises the possibility that hypertension is a predictor 
of GDM. Other studies reported similar results.
6,63,64 
Caruso et al. reported that insulin sensitivity of wom-
en with chronic hypertension and GDM was approx-
imately twofold lower than those with GDM only and 
they concluded that blood pressure is a strong predic-
tor of insulin resistance.
65 Another study has reported 
the same results.
64 Metabolic syndrome is character-
ized by presence of hypertension, insulin resistance, 
glucose intolerance, dyslipidemia and central obesi-
ty.
66 Besides, it is regarded that chronic insulin re-
sistance is central component of GDM.
67  
According to aforementioned data, we conclude that 
women with gestational diabetes have an insulin re-
sistance background. Some features of this back-
ground, such as hypertension show themselves earlier 
which can predict the occurrence of other elements, 
such as GDM, in later life. In addition to the fact that 
gestational diabetes is associated with hypertensive 
disorders, it has shown that subclinical hypothyroid-
ism could lead to hypertension, mainly high diastolic 
pressure.
68 So there is one possibility that the associa-
tion of gestational diabetes with hypertension, at least 
in part, is due to the more prevalence of hypothyroid-
ism in gestational diabetes women.   
In this study, we showed that maternal age, the 
birth weight of previous neonate, hypothyroidism, 
chronic hypertension and probably previous history 
of having a preterm birth are associated with GDM. 
Results of such studies can be used to predict the 
chance of GDM in healthy women and adopting pre-
ventive strategies in at-risk population. Although 
some studies suggest that universal screening appears 
to be the most reliable method of diagnosing GDM,
19 
in 2009, the American Diabetes Association stated 
that screening a low-risk group of pregnant women is 
probably not cost-effective.
69 Therefore, identifying 
new risk factors for GDM can increase the sensitivity 
for selection of those women benefits from oral glu-
cose tolerance test. Surely, more studies are needed to 
confirm our results. 
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